230 related articles for article (PubMed ID: 22614021)
1. Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4.
Sun Y; Cao S; Yang M; Wu S; Wang Z; Lin X; Song X; Liao DJ
Oncogene; 2013 Apr; 32(14):1794-810. PubMed ID: 22614021
[TBL] [Abstract][Full Text] [Related]
2. Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors.
López-Vicente L; Armengol G; Pons B; Coch L; Argelaguet E; Lleonart M; Hernández-Losa J; de Torres I; Ramon y Cajal S
Clin Cancer Res; 2009 Jul; 15(14):4546-53. PubMed ID: 19584160
[TBL] [Abstract][Full Text] [Related]
3. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells.
Thakur A; Sun Y; Bollig A; Wu J; Biliran H; Banerjee S; Sarkar FH; Liao DJ
Clin Cancer Res; 2008 Jul; 14(14):4427-36. PubMed ID: 18628456
[TBL] [Abstract][Full Text] [Related]
4. Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines.
Arechavaleta-Velasco F; Zeferino-Toquero M; Estrada-Moscoso I; Imani-Razavi FS; Olivares A; Perez-Juarez CE; Diaz-Cueto L
Med Oncol; 2016 Feb; 33(2):11. PubMed ID: 26732474
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of the X-linked ribosomal S6 kinase RPS6KA6 (RSK4) in endometrial cancers.
Dewdney SB; Rimel BJ; Thaker PH; Thompson DM; Schmidt A; Huettner P; Mutch DG; Gao F; Goodfellow PJ
Clin Cancer Res; 2011 Apr; 17(8):2120-9. PubMed ID: 21372219
[TBL] [Abstract][Full Text] [Related]
6. RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.
Zhu J; Li QY; Liu JL; Wei W; Yang HW; Tang W
Oncol Rep; 2015 Dec; 34(6):3156-62. PubMed ID: 26397146
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of FBP-interacting repressor coordinates c-Myc, P27Kip1/cyclinE and Ku86/XRCC5 expression as a molecular sensor for bleomycin-induced DNA damage pathway.
Rahmutulla B; Matsushita K; Satoh M; Seimiya M; Tsuchida S; Kubo S; Shimada H; Ohtsuka M; Miyazaki M; Nomura F
Oncotarget; 2014 May; 5(9):2404-17. PubMed ID: 24811221
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types.
Dümmler BA; Hauge C; Silber J; Yntema HG; Kruse LS; Kofoed B; Hemmings BA; Alessi DR; Frödin M
J Biol Chem; 2005 Apr; 280(14):13304-14. PubMed ID: 15632195
[TBL] [Abstract][Full Text] [Related]
9. Effect of RSK4 on biological characteristics of colorectal cancer.
Ye Q; Wang X; Jin M; Wang M; Hu Y; Yu S; Yang Y; Yang J; Cai J
World J Surg Oncol; 2018 Dec; 16(1):240. PubMed ID: 30579335
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.
Arechavaleta-Velasco F; Dominguez-Lopez P; Acosta-Jimenez E; Diaz-Cueto L
Mol Biol Rep; 2023 Aug; 50(8):6863-6870. PubMed ID: 37402066
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the RSK4 promoter associated with BRAF V600E promotes papillary thyroid carcinoma.
Yin Y; Che K; Hu J; Hua H; Dong A; Wang J; Yu J; Zhang Q; Zhao S; Zhao Y; Wang P; Wang F; Wang Y; Chi J; Sun W
Int J Oncol; 2020 May; 56(5):1284-1293. PubMed ID: 32319586
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
13. Differential Expression of RSK4 Transcript Isoforms in Cancer and Its Clinical Relevance.
Chen S; Seckl MJ; Lorentzen MPG; Pardo OE
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498899
[TBL] [Abstract][Full Text] [Related]
14. A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation.
Yntema HG; van den Helm B; Kissing J; van Duijnhoven G; Poppelaars F; Chelly J; Moraine C; Fryns JP; Hamel BC; Heilbronner H; Pander HJ; Brunner HG; Ropers HH; Cremers FP; van Bokhoven H
Genomics; 1999 Dec; 62(3):332-43. PubMed ID: 10644430
[TBL] [Abstract][Full Text] [Related]
15. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
Mei Y; Liao X; Zhu L; Yang H
J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma.
Fan L; Li P; Yin Z; Fu G; Liao DJ; Liu Y; Zhu J; Zhang Y; Wang L; Yan Q; Guo Y; Shao C; Huang G; Wang Z
Br J Cancer; 2013 Sep; 109(5):1137-46. PubMed ID: 23942078
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
19. RNA interference screening identifies lenalidomide sensitizers in multiple myeloma, including RSK2.
Zhu YX; Yin H; Bruins LA; Shi CX; Jedlowski P; Aziz M; Sereduk C; Kortuem KM; Schmidt JE; Champion M; Braggio E; Keith Stewart A
Blood; 2015 Jan; 125(3):483-91. PubMed ID: 25395420
[TBL] [Abstract][Full Text] [Related]
20. RSK4 inhibition results in bypass of stress-induced and oncogene-induced senescence.
López-Vicente L; Pons B; Coch L; Teixidó C; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Carcinogenesis; 2011 Apr; 32(4):470-6. PubMed ID: 21239520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
